Ethacridine inhibits SARS-CoV-2 by inactivating viral particles.

导出 OA

翻译打印收藏纠错

第一作者： Xiaoquan,Li

第一单位： Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America.;Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, United States of America.

作者： Xiaoquan,Li ^[1] ; Peter V,Lidsky ^[2] ; Yinghong,Xiao ^[2] ; Chien-Ting,Wu ^[3] ; Miguel,Garcia-Knight ^[2] ; Junjiao,Yang ^[1] ; Tsuguhisa,Nakayama ^[4] ; Jayakar V,Nayak ^[4] ; Peter K,Jackson ^[3] ; Raul,Andino ^[2] ; Xiaokun,Shu ^[1]

作者单位： Department of Pharmaceutical Chemistry, University of California, San Francisco, San Francisco, California, United States of America.;Cardiovascular Research Institute, University of California, San Francisco, San Francisco, California, United States of America. ^[1] Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, United States of America. ^[2] Department of Baxter Laboratory for Stem Cell Biology, Department of Microbiology & Immunology, Stanford University, California, United States of America. ^[3] Department of Otolaryngology-Head and Neck Surgery, Stanford University, Stanford, California, United States of America. ^[4]